Free Trial

Beneficient (BENF) Competitors

Beneficient logo
$0.29 -0.01 (-2.34%)
Closing price 03:02 PM Eastern
Extended Trading
$0.30 +0.01 (+1.71%)
As of 04:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BENF vs. LMFA, NCPL, MIGI, CARV, SLNH, MEGL, SHFS, NRBO, PWM, and SNTG

Should you be buying Beneficient stock or one of its competitors? The main competitors of Beneficient include LM Funding America (LMFA), Netcapital (NCPL), Mawson Infrastructure Group (MIGI), Carver Bancorp (CARV), Soluna (SLNH), Magic Empire Global (MEGL), SHF (SHFS), NeuroBo Pharmaceuticals (NRBO), Prestige Wealth (PWM), and Sentage (SNTG). These companies are all part of the "banking" industry.

Beneficient vs. Its Competitors

Beneficient (NASDAQ:BENF) and LM Funding America (NASDAQ:LMFA) are both small-cap finance companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, profitability, institutional ownership, analyst recommendations, earnings and valuation.

In the previous week, Beneficient had 1 more articles in the media than LM Funding America. MarketBeat recorded 2 mentions for Beneficient and 1 mentions for LM Funding America. LM Funding America's average media sentiment score of 0.00 beat Beneficient's score of -0.52 indicating that LM Funding America is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Beneficient
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Negative
LM Funding America
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

90.6% of Beneficient shares are owned by institutional investors. Comparatively, 22.7% of LM Funding America shares are owned by institutional investors. 13.7% of Beneficient shares are owned by company insiders. Comparatively, 36.1% of LM Funding America shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Beneficient has higher earnings, but lower revenue than LM Funding America.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BeneficientN/AN/AN/AN/AN/A
LM Funding America$11M1.21-$7.32M-$6.76-0.39

Beneficient has a beta of -0.59, indicating that its share price is 159% less volatile than the S&P 500. Comparatively, LM Funding America has a beta of 1.56, indicating that its share price is 56% more volatile than the S&P 500.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Beneficient
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
LM Funding America
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Beneficient has a net margin of 0.00% compared to LM Funding America's net margin of -184.48%. Beneficient's return on equity of 0.00% beat LM Funding America's return on equity.

Company Net Margins Return on Equity Return on Assets
BeneficientN/A N/A N/A
LM Funding America -184.48%-46.84%-38.06%

Summary

Beneficient and LM Funding America tied by winning 5 of the 10 factors compared between the two stocks.

Get Beneficient News Delivered to You Automatically

Sign up to receive the latest news and ratings for BENF and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BENF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BENF vs. The Competition

MetricBeneficientFIN IndustryFinance SectorNASDAQ Exchange
Market Cap$2.59M$7.44B$12.05B$8.95B
Dividend YieldN/A4.81%5.57%4.08%
P/E RatioN/A18.1320.0620.03
Price / SalesN/A5.2025.59120.16
Price / CashN/A21.6621.5057.47
Price / BookN/A2.722.285.67
Net IncomeN/A$304.38M$1.00B$248.47M
7 Day Performance1.67%6.78%2.31%2.90%
1 Month Performance-0.71%13.02%4.37%5.75%
1 Year Performance-86.42%24.93%541.13%21.36%

Beneficient Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BENF
Beneficient
0.6704 of 5 stars
$0.29
-2.3%
N/A-86.0%$2.59MN/A0.0080Upcoming Earnings
LMFA
LM Funding America
1.7527 of 5 stars
$1.86
+8.1%
N/A-35.0%$9.34M$7.03M-0.278
NCPL
Netcapital
0.5284 of 5 stars
$4.20
-1.2%
N/A+21.4%$9.23M$4.95M-0.21N/ANews Coverage
Gap Down
MIGI
Mawson Infrastructure Group
0.6097 of 5 stars
$0.45
+6.4%
N/A-69.2%$8.93M$59.26M-0.3140
CARV
Carver Bancorp
0.096 of 5 stars
$1.62
+5.2%
N/A+27.7%$8.28M$40.74M-0.84110Gap Up
SLNH
Soluna
0.9087 of 5 stars
$0.57
+3.6%
N/A-88.2%$7.84M$38.02M-0.0560
MEGL
Magic Empire Global
0.6166 of 5 stars
$1.70
-1.7%
N/A-24.2%$6.90M$1.65M0.008News Coverage
SHFS
SHF
N/A$2.24
+0.4%
N/A-79.0%$6.23M$15.24M0.663Gap Down
NRBO
NeuroBo Pharmaceuticals
N/A$0.68
-3.4%
N/A-86.1%$5.83MN/A0.0010News Coverage
PWM
Prestige Wealth
0.893 of 5 stars
$0.38
-2.6%
N/A-57.1%$5.50M$640K0.004News Coverage
Positive News
Gap Up
SNTG
Sentage
N/A$1.79
+0.6%
N/A-6.6%$5.03M$110K0.0020

Related Companies and Tools


This page (NASDAQ:BENF) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners